FREE - FreeSeas Inc.

Good Morning,

I know the old saying "good things in life are not free" but in this case
they are and FREE is going crazy pre market because its not often you
get to see a NASDAQ listed play trading in the sub .10 range.

Granted, FREE is already up and trading pre market I think the action is
just getting started on this bottom bounce monster:

RSI - Trending up in a BULLISH pattern
Price - Coming of off 52 week lows & trending up
MACD - Under the zero line, big uptrend potential
Acc/Dist - At rock bottom & bullish cross over signal.

The biggest positive here, is that FREE is a NASDAQ trading not just under
a buck like we saw last week but under .20 currently pre market.

You remember last week right? I showed you a .73 play that ran over

Well FREE closed at .07 yesterday... that's right under .10 and is currently
as I type this trending up double that price with massive volume.

So... the magic question you will ask... how high will it go...

You know, I have no idea, but the last technical resistance point is at the
50ma which is at .18, once that is tackled then price level wise .269 is in
the spot light.

Get over that range and FREE could really become FREE as it will turn into
a parabolic monster.

Start your research on FREE right away, trade wise and enjoy.



Stockchat LLC has not r.eceived any form of c.ompensation for the a.wareness of F.REE

Share this article:


VMRI - Valmie Resources Inc

Valmie Resources Inc. (VMRI)

You remember VMRI: they make DRONES, those little “military” helicopters that the FAA just cleared for BIG commercial applications.


So now that everybody from Amazon to FedEx is getting the green light to fly, the GOLD RUSH to sell them the drones is ON!


VMRI already hit the ground running with NEWS, NEWS, NEWS. And now the chart is already looking more than a little oversold:




The last time VMRI let its RSI drift to 30 and bounce back, traders got to ride a 48% rally . . . never any guarantee, but it’s a nice number!


And with the 200-day line way up around $1.40, there’s room for a similar lift and MORE if the cards stack up right.


Remember, drones are already a $13 BILLION business that should add up above $82 BILLION in the next 10 years, according to the latest stats.


That hasn’t changed. VMRI still has corporate contracts lining up and acquisition targets jumping onto its hook. Let’s review:


  • The drone story is obviously set up to be one of the next revolutions of our age. AMAZON, FEDEX and GOOGLE are thinking about delivering your package with tiny helicopters, what’s next?


  • VMRI’s edge is actually its software. They’re looking at patenting their drone intelligence systems even as we speak. Smarter drones that drive themselves and LEARN are obviously pretty special.


  • But you can’t show off your system if you don’t have the hardware. VMRI bought drone maker Vertitek to take its tech off the drawing board and in front of prospective customers! (Read more)



Bottom Line: I said it before and I’ll say it again: drones are hot stuff. Funding is up 100% over last year and every talking head wants to play.


VMRI remains a bona fide pure play. And the market just gave us a chance to play it down here at barely $1 . . . provided the chart cooperates.


Did I mention that management here just got invited to go to CHINA to talk about full mass production and maybe a little more M&A action?


You don’t talk like that unless you’re serious about vertical lift off! But evidently VMRI is not only serious but spinning up seriously FAST.


Hot industry, headline friendly. Growing at breakneck speed. That’s the VMRI we already know. Now the shares are OVERSOLD as well!


So dig in, start scanning the news wire for updates. And be ready for VMRI.



Stockcaht LLC has received four thousand dollars via a bank wire for the awareness of VMRI from a third party Action Media Holdings. Stockchat LLC has previously received Twenty Nine thousand dollars via a bank wire for the awareness of VMRI from a third party WFWS LLC which has expired.

Share this article:



Greetings, Trader!

Between the analyst chatter and an ongoing 3-digit bull run, every red-blooded trader should have SPRY Inc. (SPYR) on his radar.

And as of NOW, SPYR is set up roughly where it was when it started making truly spectacular moves -- this is the time to get to know this play!

Load that chart and you’ll see what I mean:


The market chatter has been getting hot and bothered over SPYR since new management came onboard a few months back.

But the real trigger for the bulls was when SPYR dipped close to technical oversold . . . around 30 on the RSI . . . and opened the entry window.

Since then, SPYR has been UNSTOPPABLE. The shortest move delivered 60%. Those who played it long MULTIPLIED their win.

Even the recent dip opened up a near-90% bounce! And now the RSI is exactly where it was before that move . . . right around 30!


But what has the analysts all riled up on SPYR?

  • Once upon a time, SPYR was a food company and nobody cared. Some high-powered hires later, they’ve got a network of high-tech properties and even bigger plans ahead.

  • SPYR websites are all over the place but I like how they’re catchy names people can remember: for cooks, for eaters, for beautiful people, for sweat.

  • Then you got the SPYR game, which they announced a little while back and pushed onto the Apple app store within weeks. They’re real excited about the possibility that this thing goes huge.

  • Analyst after analyst after analyst is getting awful excited about SPYR. I wonder if that’s where the 3-digit ride has come from. The suits bang the table, the stock jumps? Clearly it’s not bad for “awareness.

Bottom Line: Now we know this stock can touch within a penny of $1 per share, those analyst targets don’t look quite so outrageous.

From here it looks like SPYR has a dizzying amount of head room to “go back and fill” before it even comes close to the implied ceiling.

And with SPYR now as oversold as when it launched the near-90% rally . . . much less the 3-digit bender . . . can you really pass up a trade like this?




Stockchat LLS has received four thousand dollars via a bank wire for the awareness of SPYR from a third party Action Media Holdings.

Share this article:


PMCB - PharmaCyte Biotech Inc.



PharmaCyte Biotech Inc. (PMCB)



Biotech plays are in hot demand on Wall Street for a simple reason: these companies are where the top brains are solving big money diseases.



I’m talking massive medical opportunities like cancer ($100B) and diabetes ($245B), chances to build a pharma empire from the ground up.

Along the way, of course, there are plenty of shots at quicker glory . . . which is exactly where PMCB comes leaping back onto my screen.

As you recall from its last bull run for us, PMCB has taken a potential CURE FOR DIABETES through its first pre-clinical trial. (Read more)

That’s incredibly ambitious for any 0.15 start-up, but in the here and now I want you to look at the technical situation forming on PMCB:





The tight channel PMCB has explored in the last couple weeks has created a platform for the next move . . . reminiscent of back in March, right before the PPS lifted off on a 3-digit bull run.


Of course it takes a signal for any market rocket to blast. That’s where the biotech buzz comes to the table. As you recall, the skeleton key to PMCB’s technology is putting “good” cells in a tiny box where they can go into the body and release tumor-killing drugs right where they’re needed.

Find the right cells and in theory PMCB can cure cancer, repair a sick diabetic pancreas, you name it. They already proved in the lab that the cell boxes work, and that pre-clinical trial shows that they’re safe to implant in living animals.

One tiny demonstration of how important this technology might be: PMCB has official FDA “orphan” status to try its boxes out on pancreatic cancer. The average orphan drug that makes it through the process is worth $1B . . . no surprise big pharma execs are happy to get a piece of the action.

And no wonder the analysts are jumping all over each other to assign some brain-meltingly high targets on what PMCB may actually be worth. That one I linked to tells a 4-digit story!

Analyst coverage? Extreme price targets? FDA perks? Big pharma talent crowding the board? It looks to me like PMCB has a lot of the puzzle pieces to become one of those gigantic biotech companies you read about in Barrons.


But unlike those companies, PMCB is still available in 0.01 increments instead of multiple Benjamins per share. But talk about ground floor rising! Remember, every tiptoe toward the clinic unlocks value.

The clock is ticking. The base has been established. It’s time to see PMCB strut its stuff!











Stockchat LLC has received four thsnd dlrs via a bank wire for the awareness of PMCB from a third party Action Media Holdings.


Share this article:


PCSV - PCS Edventures Inc

PCS Edventures Inc. (PCSV)

One of the biggest thrills in the market boils down to finding a company right on the verge of moving to the next level. That’s where PCSV is now.

PCSV designs and sells programs that teach kids about STEM (Science, Technology, Engineering and Math). That’s a huge educational priority for the White House, Bill Gates and an all-star cast.

Demand for STEM classes is so intense that PCSV more than DOUBLED its sales last year and even posted an operating profit last quarter.

You don’t see the “P” word often with these stocks that trade around $0.05 to $0.10. The fact that PCSV is throwing it around now is extraordinary.

And even a novice trader can appreciate what the one-time transition to EBITDA does to a start-up chart like PCSV:

PCSV The buzz on PCSV has gotten so fierce that news of even
standard product launch has started triggering 200%
bull runs



The market knows that PCSV is already in the scoring
zone. “Economies of scale” are already working in its
favor. So every new order and every new product
the needle
of fair value harder and faster.


As it is, the VOLUME on PCSV so far this month is tracking above double March levels. That’s a BULLISH signal.

The latest press release drove PRICE ACTION so far through the roof that it smashed all moving averages and the upper Bollinger Band. BULLISH.

Traders took profit on the last 200% score, but the ACCUMULATION floor is still higher. Fewer PCSV shares in circulation is BULLISH.

And look at what the big move did to the MACD: anyone with a trade screen can see that the TREND on PCSV is MIGHTY BULLISH indeed.

What’s the big deal about STEM lessons? Every country on the planet needs to train higher-tech workers. It’s a $2.9 BILLION budget item.

The White House just freed up another $240 million in grants to promote STEM education, including $90 million to teach “underrepresented” kids (minorities and girls) more math.

PCSV is already in position to do that. Here’s their program for girls, practically gift wrapped for a slice of that rich government largesse.

Meanwhile they’re raking in 6- and 7-figure orders for the existing lessons. There’s $400,000 over here, $120,000 from Texas, ten times that much sales to Saudi Arabia.

All in, PCSV has started booking revenue at a run rate around $3 million a year. Since cash flow now matches market cap, that’s a real achievement.

Whether you like EV/Sales or PTR as your top line metric, PCSV is clearly evolving beyond the sandbox where a lot of $0.05 stocks play.

EBITDA isn’t enormous yet, but it’s POSITIVE . . . and besides, that’s the thrill in trading on our end of the market.

We know PCSV is still pretty close to the ground floor. There’s a long way to go before it’s an educational powerhouse.

But with actual EBITDA on the books, we can see that the fundamental floor is rising. Recent price action and all that momentum say it all.

If that’s the kind of trade that gets you excited, PCSV probably already has your gears spinning ahead of tomorrow’s open. You’re our kind of people!































Stockchat LLC has received seven thousand dlrs via a bank wire from a third party.

Share this article:

Copyrights © 2015. Today's Stock Tip